Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
この品目はお気に入りに追加されました。
動物種
パネルタイプ
選択したキット
数量
カタログ番号
注文内容
Qty/Pk
価格
96-Well Plate
数量
カタログ番号
注文内容
Qty/Pk
価格
その他の試薬を追加 （MAPmatesとともに使用するにはバッファーおよび検出キットが必要です）
数量
カタログ番号
注文内容
Qty/Pk
価格
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option（チェックを入れると箱詰めから袋詰めに変更となりますのでご注意ください） Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
It is not recommended for immunohistochemistry or in situ hybridization. Functionality check performed on final product by dot blot. Additional QC testing is preformed on a lot-specific basis: pH: 9.7-9.9 Stability at 4°C Stability at 18-26°C
Suggested procedure for immunoblot staining with BCIP/NBT:
1. Complete all required incubations with antibodies and alkaline-phosphatase-labeled probes. 2. After the final binding reaction with the alkaline-phosphatase labeled probe, wash the membrane thoroughly in a buffer such as Tris-buffered saline (TBS) containing 0.1% Tween®-20 detergent. DO NOT USE PHOSPHATE BUFFERS; inorganic phosphate is a potent inhibitor of alkaline phosphatase. 3. Following the final wash, completely cover the membrane with BCIP/NBT Solution and incubate, protected from light, for 5-15 min, or until the desired color intensity is obtained (dark purple bands or dots will appear at the sites of enzyme activity). Note: Variables associated with assay conditions will dictate the proper reaction time. If the color develops almost immediately, the NBT-formazan deposit may flake off the membrane. If this occurs, further dilution of the alkaline phosphatase probe is recommended. A fine line of formazan deposit circumscribing the band or dot, with no deposit in the center, also suggests that further dilution of the alkaline phosphatase probe is needed. 4. Stop the reaction by washing the membrane thoroughly in distilled water. Note: There should be little or no background. Presence of excessive background staining indicates incomplete removal of unbound alkaline phosphatase from the membrane. To remedy this problem, increase the number of wash steps or washing times. 5. Air-dry membranes and store at room temperature, protected from light.
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Standard Handling
Storage
+2°C to +8°C
Protect from Light
Protect from light
Do not freeze
Ok to freeze
Special Instructions
Discard if the solution turns purple or turbid. The reagent is stable at room temperature, but we recommend storage in the refrigerator to increase the shelf life. Warm to assay temperature before use.
De Jong, A.S., et al. 1985. Histochem. J.17, 1119.
データシート
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
BCIP/NBT provided as a stable single component, ready-to-use substrate, sterile-filtered through a 0.22 µm filter. Specifically designed for immunoblotting techniques. BCIP/NBT is the substrate of choice for alkaline phosphatase-based immunoblotting procedures. Hydrolysis of the phosphate ester of BCIP by alkaline phosphatase yields powerful reducing compounds that react rapidly with NBT and convert it to the insoluble NBT-formazan. This reaction product is readily visible on the blotting membrane as dark purple deposits that do not fade upon drying.
Background
BCIP/NBT is the substrate of choice for alkaline phosphatase-based immunoblotting procedures. Hydrolysis of the phosphate ester of BCIP by alkaline phosphatase yields powerful reducing compounds that react rapidly with NBT and convert it to the insoluble NBT-formazan. This reaction product is readily visible on the blotting membrane as dark purple deposits that do not fade upon drying.
Form
Clear to pale yellow liquid
Formulation
0.577 mM BCIP, 0.122 mM NBT in a proprietary solution.
Recommended reaction conditions
Suggested procedure for immunoblot staining with BCIP/NBT:
1. Complete all required incubations with antibodies and alkaline-phosphatase-labeled probes.
2. After the final binding reaction with the alkaline-phosphatase labeled probe, wash the membrane thoroughly in a buffer such as Tris-buffered saline (TBS) containing 0.1% Tween®-20 detergent. DO NOT USE PHOSPHATE BUFFERS; inorganic phosphate is a potent inhibitor of alkaline phosphatase.
3. Following the final wash, completely cover the membrane with BCIP/NBT Solution and incubate, protected from light, for 5-15 min, or until the desired color intensity is obtained (dark purple bands or dots will appear at the sites of enzyme activity).
Note: Variables associated with assay conditions will dictate the proper reaction time. If the color develops almost immediately, the NBT-formazan deposit may flake off the membrane. If this occurs, further dilution of the alkaline phosphatase probe is recommended. A fine line of formazan deposit circumscribing the band or dot, with no deposit in the center, also suggests that further dilution of the alkaline phosphatase probe is needed.
4. Stop the reaction by washing the membrane thoroughly in distilled water.
Note: There should be little or no background. Presence of excessive background staining indicates incomplete removal of unbound alkaline phosphatase from the membrane. To remedy this problem, increase the number of wash steps or washing times.
5. Air-dry membranes and store at room temperature, protected from light.
Preservative
None
Comments
It is not recommended for immunohistochemistry or in situ hybridization. Functionality check performed on final product by dot blot. Additional QC testing is preformed on a lot-specific basis: pH: 9.7-9.9 Stability at 4°C Stability at 18-26°C
Suggested procedure for immunoblot staining with BCIP/NBT:
1. Complete all required incubations with antibodies and alkaline-phosphatase-labeled probes. 2. After the final binding reaction with the alkaline-phosphatase labeled probe, wash the membrane thoroughly in a buffer such as Tris-buffered saline (TBS) containing 0.1% Tween®-20 detergent. DO NOT USE PHOSPHATE BUFFERS; inorganic phosphate is a potent inhibitor of alkaline phosphatase. 3. Following the final wash, completely cover the membrane with BCIP/NBT Solution and incubate, protected from light, for 5-15 min, or until the desired color intensity is obtained (dark purple bands or dots will appear at the sites of enzyme activity). Note: Variables associated with assay conditions will dictate the proper reaction time. If the color develops almost immediately, the NBT-formazan deposit may flake off the membrane. If this occurs, further dilution of the alkaline phosphatase probe is recommended. A fine line of formazan deposit circumscribing the band or dot, with no deposit in the center, also suggests that further dilution of the alkaline phosphatase probe is needed. 4. Stop the reaction by washing the membrane thoroughly in distilled water. Note: There should be little or no background. Presence of excessive background staining indicates incomplete removal of unbound alkaline phosphatase from the membrane. To remedy this problem, increase the number of wash steps or washing times. 5. Air-dry membranes and store at room temperature, protected from light.
Storage
Protect from light
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Discard if the solution turns purple or turbid. The reagent is stable at room temperature, but we recommend storage in the refrigerator to increase the shelf life. Warm to assay temperature before use.
Toxicity
Standard Handling
References
De Jong, A.S., et al. 1985. Histochem. J.17, 1119.
